932718-75-7

Upstream product

• 932718-73-5 benzoic acid (2R,3S,4R)-3-benzyloxy-2-hydroxy-4-methyl-hex-5-enyl ester 
• 124-63-0 methanesulfonyl chloride 
• 88406-01-3 2,3-O-isopropylidene-1-C-<(1R)-1-methylprop-2-enyl>-D-erythro-glycerol 
• 100-39-0 benzyl bromide 
• 109121-41-7 (R)-4-((1S,2R)-1-benzyloxy-2-methylbut-3-enyl)-2,2-dimethyl-[1,3]dioxolane 
• 115408-60-1 (2R,3S,4R)-3-benzyloxy-4-methylhex-5-ene-1,2-diol 

Downstream Products

• 932718-77-9 (2S,3S,4R)-3-benzyloxy-1-methoxy-4-methyl-hex-5-en-2-ol 
• 932718-58-6 (2S,3S,4S)-3-benzyloxy-5-methoxy-2-methyl-4-triisopropylsilanyloxy-pentanal 
• 932718-56-4 ((1S,2S,3R)-2-benzyloxy-1-methoxymethyl-3-methyl-pent-4-enyloxy)-triisopropylsilane 
• 932718-79-1 ((1S,2S,3R)-2-benzyloxy-1-methoxymethyl-3-methyl-pent-4-ynyloxy)-triisopropylsilane 
• 932718-54-2 (S)-((1S,2R)-1-benzyloxy-2-methyl-but-3-enyl)-oxirane 

Relevant academic research and scientific papers

Crotylation versus propargylation: Two routes for the synthesis of the C13-C18 fragment of the antibiotic branimycin

The C13-C18 fragment 3 of the novel antibiotic branimycin was prepared along two highly stereocontrolled routes. The first one uses a standard Roush crotylation protocol, whereas the second one proceeds via an allenyl silane propargylation with unexpected stereochemical consequences, which are discussed in detail.